hip and knee replacement
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients eligible for this trial are patients with clinical and radiological knee or hip OA who are scheduled for a primary TKA or THA, and willing to comply with the study protocol.
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: TKA or THA for a diagnosis other than OA, uncontrolled cardiovascular disease or hypertension, history of neuromuscular disorder that affects lower extremity function, terminal illness, plans to have another joint replacement during study follow-up, not able to attend follow-up measurements, not able to attend the PPT in primary setting, serious adverse events during surgery or directly thereafter, serious psychiatric disorders, or insufficient command of the Dutch language, spoken and/or written.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference between both groups regarding changes of KOOS-PS/HOOS-PS, a measure of physical functioning, between baseline and 3 months postoperatively. Differences between both groups regarding cost-effectiveness. | — |
Secondary
| Measure | Time frame |
|---|---|
| Differences between both groups in: - recovery of function during 12 months follow-up, - in scores of OKS/OHS (functioning), NRS (amount of pain), EQ-5D (quality of life), performance tests, physical activity level, and satisfaction of the patient. | — |
Countries
Netherlands